Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Psychosis pathophysiology may involve insula dysfunction, a brain region critical for processing motivationally salient stimuli.
• The antipsychotic potential of cannabidiol (CBD) is recognized, but its underlying mechanisms, particularly concerning insular function, require further elucidation.

Purpose of the Study:

• To investigate if cannabidiol's (CBD) antipsychotic effects are mediated by its influence on insular activation.
• To examine the impact of CBD on salience processing within the insula in individuals with early psychosis.

Main Methods:

• A within-subject, crossover, double-blind, placebo-controlled study involving 15 participants with early psychosis and 19 healthy controls.
• Functional magnetic resonance imaging (fMRI) was employed during a monetary incentive delay task to assess brain activation.
• A single dose of CBD was compared against a placebo, focusing on brain responses to reward and loss anticipation.

Main Results:

• No significant differences in brain activation were found between psychosis patients and healthy controls.
• Cannabidiol (CBD) administration led to an attenuation of insula activation compared to placebo.
• Sensitivity analyses confirmed that current cannabis use history did not alter these findings.

Conclusions:

• The study findings support existing evidence that CBD modulates brain regions involved in salience processing.
• Further research is necessary to determine if these observed effects on insular activation underlie the potential antipsychotic properties of CBD.